MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC)

被引：28

作者：

Duan, Xianchun ^{[2
]}

Hu, Jianpeng ^{[1
]}

Wang, Yongzhong ^{[2
]}

Gao, Jiarong ^{[2
]}

Peng, Daiyin ^{[1
]}

Xia, Lunzhu ^{[2
]}

机构：

[1] Anhui Univ Chinese Med, Hefei 230031, Anhui, Peoples R China

[2] Anhui Univ Chinese Med, Affiliated Hosp 1, Hefei 230031, Anhui, Peoples R China

来源：

GENE | 2014年 / 541卷 / 01期

关键词：

miR-145; Hepatocellular carcinoma; MIR-145; PATHWAY;

D O I：

10.1016/j.gene.2014.03.018

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

It has been demonstrated that microRNA-145 (miR-145) is downregulated in patients with hepatocellular carcinoma (HCC) compared with healthy controls. The mechanisms for miR-145 in HCC will become potential in future researches. (C) 2014 Elsevier B.V. All rights reserved.

引用

页码：67 / 68

页数：2

共 8 条

[1] Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis [J].

Gao, Peng ;

Wong, Carmen Chak-Lui ;

Tung, Edmund Kwok-Kwan ;

Lee, Joyce Man-Fong ;

Wong, Chun-Ming ;

Ng, Irene Oi-Lin .

JOURNAL OF HEPATOLOGY, 2011, 54 (06) :1177-1184

[2] Cyclin g1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma [J].

Gramantieri, Laura ;

Ferracin, Manuela ;

Fornari, Francesca ;

Veronese, Airtgelo ;

Sabbioni, Silvia ;

Liu, Chang-Gong ;

Calin, George A. ;

Giovannini, Catia ;

Ferrazzi, Eros ;

Grazi, Gian Luca ;

Croce, Carlo M. ;

Bolondi, Luigi ;

Negrini, Massimo .

CANCER RESEARCH, 2007, 67 (13) :6092-6099

[3] Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance [J].

Karakatsanis, Andreas ;

Papaconstantinou, Ioannis ;

Gazouli, Maria ;

Lyberopoulou, Anna ;

Polymeneas, George ;

Voros, Dionysios .

MOLECULAR CARCINOGENESIS, 2013, 52 (04) :297-303

[4] MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma [J].

Law, Priscilla T. -Y. ;

Ching, Arthur K. -K. ;

Chan, Anthony W. -H. ;

Wong, Queenie W. -L. ;

Wong, Chun-Kwok ;

To, Ka-Fai ;

Wong, Nathalie .

CARCINOGENESIS, 2012, 33 (06) :1134-1141

[5] MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer [J].

Noh, Ji Heon ;

Chang, Young Gyoon ;

Kim, Min Gyu ;

Jung, Kwang Hwa ;

Kim, Jeong Kyu ;

Bae, Hyun Jin ;

Eun, Jung Woo ;

Shen, Qingyu ;

Kim, Seung-Jin ;

Kwon, So Hee ;

Park, Won Sang ;

Lee, Jung Young ;

Nam, Suk Woo .

CANCER LETTERS, 2013, 335 (02) :455-462

[6] Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma [J].

Wang, Lei ;

Guo, Zhang-Yan ;

Zhang, Rui ;

Xin, Bo ;

Chen, Rui ;

Zhao, Jing ;

Wang, Tao ;

Wen, Wei-Hong ;

Jia, Lin-Tao ;

Yao, Li-Bo ;

Yang, An-Gang .

CARCINOGENESIS, 2013, 34 (08) :1773-1781

[7] ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway [J].

Wang, Xiang-jun ;

Feng, Chang-wei ;

Li, Min .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 380 (1-2) :57-66

[8]

Yang X.W., 2013, HEPATOLOGY RES

← 1 →